Antifungal Activity of Nanocarriers Containing Tea Tree oil on the Growth of c. Albicans: An Inhibition Profile Study
DOI:
https://doi.org/10.5902/2179460X19528Keywords:
Candida albicans. Nanoemulsions. Nanocapsules. Tea tree oil.Abstract
The aim of this study was to evaluate, for the first time, the antifungal efficacy of nanocapsules suspension and nanoemulsions containing Melaleuca alternifolia essential oil (tea tree oil). Methods and results: An in vitro assay measuring antimicrobial activity against Candida albicans was performed in order to obtain an inhibition profile after 0, 5, 8, 12, 24, 48 and 72 h growth, using two different yeast concentration. The activity of oil-loaded nanostructures on C. albicans growth curve showed differences between formulations. For small concentrations of microorganism, the formulations significantly decreased yeast charge for 48 h. Moreover, the control of growth provided by the nanocapsules remained similar at all analysis times. Conclusions: The inclusion of the oil in nanocapsules proved to be more efficient in reducing and controlling C. albicans growth.
Downloads
References
Cevc G, Vierl U. Nanotechnology and the transdermal route. A state of the art review and critical appraisal. J. Control. Release. 2010;141:277–299.
Noskin GA, Rubin RR, Schentag JJ, Kluytmans J, Hedblom EC, Smulders M et al. The burden of Staphylococcus aureus Infections on Holpitals in the United States. Arch. Intern. Med. 2005;165(15):1756-1761.
Jayatilake JAMS, Tilakaratne WM, Panagoda GJ. Candidal onychomycosis: A Mini-Review. Mycopathologia. 2009;168:165-173.
Sidrim JJC, Rocha MFG. Micologia médica à luz de autores contemporâneos. Rio de Janeiro: Guanabara Koogan S.A., Copyright; 2004.
Degreef H. Clinical Forms of dermatophytosis (Ringworm Infection). Mycopathologia. 2008;166:257-265.
Martinez-Rossi NM, Peres NTA, Rossi A. Antifungal Resistance Mechanisms in Dermatophytes. Mycopathologia;2008;166:369-383.
Mignon B, Tabart J, Baldo A, Mathy A, Losson B, Vermout S. Immunization and dermatophytes. Curr. Opin. Infect. Dis. 2008;21:134–140.
Vermout S, Tabart J, Baldo B, Mathy A, Losson B, Mignon B. Pathogenesis of Dermatophytosis. Mycopathologia. 2008;166:267–275
Khengar RH, Jones SA, Turner RB, Forbes B, Brown MB. Nail swelling as a Pre-formulation Screen for the Selection an Optimisation of Ungual Penetration Enhancers. Pharm. Research. 2007;24(12):2207-2212.
Repka MA, Mididoddi PK, Stodghill SP. Influence of human nail etching for the assessment of topical onychomicosis therapies. Int. J. Pharm. 2004;282:95-106.
Kanbe T. Molecular Approaches in the Diagnosis of Dermatophytosis. Mycopathologia. 2008;166:307–317.
Gupta AK, Chow M, Daniel CR, Aly R. Treatments of tinea pedis. Dermatol. Clin. 2003;21:431- 462.
Murdan S. Drug delivery to the nail following topical application. Int. J. Pharm. 2002;236:1- 26.
Gupta AK, Tu LQ. Therapies for Onychomycosis: A Review. Dermatol. Clin. 2006;24:375–379.
Kaur IP, Kakkar S. Topical delivery of antifungal agents. Expert Opin. Drug Del. 2010:1-25.
Güngör S, Erdal MS, Aksu B. New Formulation Strategies in Topical Antifungal Therapy. Journal of Cosmetics, Dermatological Sciences and Applications. 2013;3:56-65.
Buck SD, Nidore DM, Addino JG. Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia (tea tree) oil and clotrimazole. J. Pham. Practice. 1994;38(6):601-05.
Syed TA, Qureshi ZA, Ali SM, Ahmad SA. Treatment of toenail onychomycosis with 2% butenafine and 5% Melaleuca alternifolia (tea tree ) oil in cream. Trop. Med. Int. Health. 1999;4(4):284-287.
Nascimento PFC, Nascimento AC, Rodrigues CS, Antoniolli AR, Santos PO, Júnior AMB et al. Atividade antimicrobiana dos óleos essenciais: uma abordagem multifatorial de métodos. Rev. Bras. Farmacog. 2007;17(10):108-113.
Bakkali F, Averbeck S, Averbeck D, Idaormar M. Biological effects of essential oils- A review. Food Chem. Toxicol. 2008; 46:446-475.
Hart PH, Brand C, Carson CF, Riley TV, Prager RH, Finlay-Jones JJ. Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes. Inflamm. Res. 2000;49:619-626.
Carson CF, Hammer KA, Riley TV. Melaleuca alternifolia (Tea Tree) Oil: a Review of Antimicrobial and Other Medicinal Properties. Clin. Microbiol. Rev. 2006;19(1):50-62.
Hammer KA, Carson CF, Riley TV, Nielsen JB. A review of the toxicity of Melaleuca alternifolia (tea tree) oil. Food Chem. Toxicol. 2006;44:616-625.
Guterres SS, Alves MP, Pohlmann AR. Polymeric nanoparticles, nanospheres and nanocapsules, for cutaneous applications. Drug Target Insights. 2007;2:147-157.
Mishra B, Patel BB, Tiwari S. Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery. Nanomedicine: Nanotechnology, Biology and Medicine. 2010;6:9-24.
Flores FC, Ribeiro RF, Ourique AF, Pohlmann AR, Beck RCR, Guterres SS et al. Nanostructurated systems containing an essential oil: protection against volatilization. Quim. Nova. 2011(34):968-972.
Mora-Huertas CE, Fessi H, Elaissari A. Polymer-based nanocapsules for drug delivery. Int. J. Pharm. 2010(385):113-142.
Flores FC, Lima JA, Ribeiro RF, Rolim CMB, Beck RCR, Silva CB. Antifungal Activity of Nanocapsule Suspensions Containing Tea Tree Oil on the Growth of Trichophyton rubrum. Mycopathologia. 2013;175(3-4):281.
Bouchemal K, Briançon S, Perrier E, Fessi H. Nano-emulsion formulation using spontaneous emulsification: solvent, oil and surfactant optimization”, Int. J. Pharm. 2004;280:241-251.
Fessi H, Puisieux F, Devissaguet J, Ammoury N, Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement, Int. J. Pharm. 1989 ;55(1) :R1-4.
Anton N, Benoit J-P, Saulnier P. Design and production of nanoparticles formulated from nano-emulsion templates – A review. J. Control. Release. 2008;128:185-199.
Fontana MC, Coradini K, Guterres SS, Pohlmann AR, Beck RCR. Nanoencapsulation as a Way to Control the Release and to Increase the Photostability of Clobetasol Propionate: Influence of the Nanostructured System. Journal of Biomedical and Nanotechnology. 2009;5:1-10.
Poletto FS, Jäger E, Cruz L, Pohlmann AR, Guterres SS. The effect of polymeric wall on the permeability of drug-loaded nanocapsules. Mat. Sci. Eng. 2008;28:472-478.
Ranjita S, Loaye AS, Khalil M. Present status of Nanoparticle Research for Treatment of Tuberculosis. J. Pharm. Sci. 2011;4(1):100-116.
Gunt H, Kasting GB. Effect of hydration on the permeation of ketonazole through human nail plate in vitro. Eur. J. Pharm. Sci. 2007;32:254-60.
Downloads
Published
How to Cite
Issue
Section
License
To access the DECLARATION AND TRANSFER OF COPYRIGHT AUTHOR’S DECLARATION AND COPYRIGHT LICENSE click here.
Ethical Guidelines for Journal Publication
The Ciência e Natura journal is committed to ensuring ethics in publication and quality of articles.
Conformance to standards of ethical behavior is therefore expected of all parties involved: Authors, Editors, Reviewers, and the Publisher.
In particular,
Authors: Authors should present an objective discussion of the significance of research work as well as sufficient detail and references to permit others to replicate the experiments. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable. Review Articles should also be objective, comprehensive, and accurate accounts of the state of the art. The Authors should ensure that their work is entirely original works, and if the work and/or words of others have been used, this has been appropriately acknowledged. Plagiarism in all its forms constitutes unethical publishing behavior and is unacceptable. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behavior and is unacceptable. Authors should not submit articles describing essentially the same research to more than one journal. The corresponding Author should ensure that there is a full consensus of all Co-authors in approving the final version of the paper and its submission for publication.
Editors: Editors should evaluate manuscripts exclusively on the basis of their academic merit. An Editor must not use unpublished information in the editor's own research without the express written consent of the Author. Editors should take reasonable responsive measures when ethical complaints have been presented concerning a submitted manuscript or published paper.
Reviewers: Any manuscripts received for review must be treated as confidential documents. Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage. Reviewers should be conducted objectively, and observations should be formulated clearly with supporting arguments, so that Authors can use them for improving the paper. Any selected Reviewer who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the Editor and excuse himself from the review process. Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.
